Research,
development and innovation

Innovation plays an important role in overcoming global challenges and is a key
driver of future growth at Bayer.

In 2010 Bayer spent €3,053 million on research and development (R&D), which was equivalent to 8.7 percent of sales. Special importance is placed on developing new products that strengthen the core businesses. » more

Research and Development in Bayer
Bayer Korea’s investment
Bayer is committed to contributing to the development of the pharmaceutical industry in Korea through a variety of studies including early clinical studies, while expanding business areas by encouraging active investment in the research and development sector in South Korea. » more

A journey through the world of research at Bayer
Science for a Better Life
Bayer is an inventor company and intends to continue in this tradition of innovation in the future. In 2004, the company invested some 2.3 billion euros in research and development. High levels of investment alone do not form the basis for success at Bayer however: another important cornerstone is creativity. » more

Climate Program
Enhanced Climate commitment
Bayer positioned itself as a pioneer in climate protection with an ambitious Climate Program. The company had invested around €1 billion in this area by 2010. These investments focused on targeted cuts in greenhouse gas emissions and increases in energy and resource efficiency both at Bayer itself and in its customers’ facilities. » more

Podcast Center